Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.690
-0.030 (-1.10%)
Aug 20, 2026, 3:08 PM EDT - Market open
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $68.33 million as of August 20, 2026. Its market cap has increased by 33.05% in one year.
Market Cap
68.33M
Enterprise Value
49.06M
1-Year Change
33.05%
Ranking
Category
Stock Price
$2.69
ChartMarket Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $68.33M, a decrease of -45.39%. That is a compound annual growth rate of -22.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 68.33M | 234.93% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eloxx Pharmaceuticals | 73.28M |
| Pliant Therapeutics | 72.45M |
| Spero Therapeutics | 71.63M |
| XBiotech | 70.43M |
| Cardiff Oncology | 69.85M |
| Champions Oncology | 68.63M |
| PMV Pharmaceuticals | 68.26M |
| MindWalk Holdings | 68.13M |